Tianshui Zhongxing Bio-technology Co.,Ltd.
Shenzhen Stock ExchangeTotal Valuation
Tianshui Zhongxing Bio-technology Co.,Ltd. carries a market capitalization of 4.91B, placing it among publicly traded companies globally. Its enterprise value stands at 3.99B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.91B |
| Enterprise Value | 3.99B |
Share Statistics
Tianshui Zhongxing Bio-technology Co.,Ltd. currently has 393.24M shares outstanding.
| Shares Outstanding | 393.24M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Tianshui Zhongxing Bio-technology Co.,Ltd. trades at a trailing price-to-earnings ratio of 17.50. The price-to-sales ratio is 1.52, and the price-to-book ratio stands at 2.24.
| PE Ratio | 17.50 |
| PS Ratio | 1.52 |
| PB Ratio | 2.24 |
| P/TBV Ratio | 1.01 |
| P/FCF Ratio | 9.05 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Tianshui Zhongxing Bio-technology Co.,Ltd. trades at an EV/EBITDA multiple of 22.65 and an EV/FCF ratio of 10.22. The EV/Sales ratio of 2.07 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 22.65 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.07 |
| EV / EBITDA | 22.65 |
| EV / EBIT | 22.65 |
| EV / FCF | 10.22 |
Financial Position
Tianshui Zhongxing Bio-technology Co.,Ltd. maintains a current ratio of 1.99, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 82.61, indicating elevated leverage, while an interest coverage ratio of 2.67 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.99 |
| Quick Ratio | 1.07 |
| Debt / Equity | 82.61 |
| Debt / EBITDA | 15.29 |
| Interest Coverage | 2.67 |
Financial Efficiency
Tianshui Zhongxing Bio-technology Co.,Ltd. posts a return on equity of 13.03 and a return on invested capital of 3.02.
| Return on Equity (ROE) | 13.03 |
| Return on Assets (ROA) | 2.65 |
| Return on Invested Capital (ROIC) | 3.02 |
| Return on Capital Employed (ROCE) | 6.17 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.17 |
Stock Price Statistics
Tianshui Zhongxing Bio-technology Co.,Ltd.'s stock has gained approximately 62.45353% over the past 52 weeks. The 50-day moving average sits at 14.32, while the 200-day moving average is 14.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | 62.45353% |
| 50-Day Moving Average | 14.32 |
| 200-Day Moving Average | 14.67 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tianshui Zhongxing Bio-technology Co.,Ltd. generated 1.93B in revenue and converted that into 167.57M in net income, yielding earnings per share of 0.44. EBITDA reached 175.98M, while operating income came in at 175.98M.
| Revenue | 1.93B |
| Gross Profit | 417.47M |
| Operating Income | 175.98M |
| Pretax Income | 166.07M |
| Net Income | 167.57M |
| EBITDA | 175.98M |
| EBIT | 175.98M |
| Earnings Per Share (EPS) | 0.44 |
Balance Sheet
Tianshui Zhongxing Bio-technology Co.,Ltd. holds 1.64B in cash and equivalents against 2.69B in total debt, resulting in a net debt position of 650.49M. Total book value stands at 1.31B, with working capital of 1.51B providing operational flexibility.
| Cash & Cash Equivalents | 1.64B |
| Total Debt | 2.69B |
| Net Debt | 650.49M |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 3.48 |
| Working Capital | 1.51B |
Cash Flow
After subtracting -323.86M in capital expenditures, free cash flow totaled -323.86M - equivalent to -0.86 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -323.86M |
| Free Cash Flow | -323.86M |
| FCF Per Share | -0.86 |
Margins
Tianshui Zhongxing Bio-technology Co.,Ltd. operates with a gross margin of 21.65, reflecting its pricing power and cost economics. The operating margin of 9.13 and net profit margin of 8.69 provide insight into operational efficiency.
| Gross Margin | 21.65 |
| Operating Margin | 9.13 |
| Pretax Margin | 8.61 |
| Profit Margin | 8.69 |
| EBITDA Margin | 9.13 |
Dividends & Yields
The company's payout ratio of 114.55 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.50 |
| Dividend Yield | N/A |
| Payout Ratio | 114.55 |
| Shareholder Yield | 0.43 |
| FCF Yield | 11.05 |
Stock Splits
Tianshui Zhongxing Bio-technology Co.,Ltd.'s most recent stock split took place on April 15, 2016 with a 1000000:2051299 split ratio.
| Last Split Date | 4/15/2016 |
| Split Ratio | 1000000:2051299 |
Scores
Tianshui Zhongxing Bio-technology Co.,Ltd. posts an Altman Z-Score of 1.46, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.46 |